Lupin unveils Rocuronium Bromide Injection in US Ruchika Sharma8 Nov 2023 2:30 PM ISTMumbai: Global pharma major Lupin Limited today announced the launch of Rocuronium Bromide Injection, 50 mg/5 mL (10 mg/mL) and 100 mg/10 mL (10...
Lupin gets tentative USFDA nod for Canagliflozin, Metformin Hydrochloride ER tablets Ruchika Sharma8 Nov 2023 10:52 AM ISTCanagliflozin and Metformin Hydrochloride Extended-Release Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in...
Indian pharmaceutical market registers 9 percent growth in September: IQVIA Report Susmita Roy3 Nov 2023 5:43 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) has witnessed a spike of nine percent in September 2023, according to International Quality and...
Zydus Lifesciences, Lupin to co-market Saroglitazar Mg for chronic liver diseases treatment in India Ruchika Sharma3 Nov 2023 3:30 PM ISTUnder the terms of this agreement, Lupin will have semi-exclusive rights to co-market the product in India under the brand name LINVAS.
Lupin unveils Diazepam Rectal Gel in US Ruchika Sharma3 Nov 2023 11:34 AM ISTMumbai: Global pharma major Lupin Limited has announced the launch of Diazepam Rectal Gel, 10 mg and 20 mg, Rectal Delivery System, after its wholly...
Lupin secures tentative USFDA nod for Selexipag for Injection Ruchika Sharma2 Nov 2023 4:30 PM ISTThis product will be manufactured at Lupin's Nagpur facility in India.
Lupin gets USFDA EIR for Mandideep Unit 2 manufacturing facility Ruchika Sharma1 Nov 2023 3:45 PM ISTMumbai: Global pharma major Lupin Limited has announced that the Company has received the Establishment Inspection Report (EIR) from the United States...
Lupin bags tentative USFDA nod for generic equivalent of Janssen Biotech Erleada Tablets Ruchika Sharma14 Oct 2023 1:00 PM ISTMumbai: Global pharma major Lupin Limited has announced that the Company has received tentative approval from the United States Food and Drug...
Lupin gets tentative USFDA nod for generic equivalent of Xywav Oral Solution Ruchika Sharma13 Oct 2023 12:38 PM ISTLupin is exclusive first-to-file and may be eligible to receive a 180-day exclusivity period at product launch.
Lupin Tolvaptan tablets wins USFDA okay Ruchika Sharma6 Oct 2023 11:36 AM ISTThis product will be manufactured at Lupin's Nagpur facility in India.
USFDA issues EIR for Lupin Nagpur Unit-1 manufacturing facility Ruchika Sharma30 Sept 2023 10:00 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received the Establishment Inspection Report (EIR) from the United States Food and...
Lupin buys five brands from Menarini Ruchika Sharma22 Sept 2023 5:10 PM ISTThe brands are Piclin (Picosulphate Sodium), Menoctyl (Otilonium Bromide), Sucramal O (Sucralfate + Oxetacaine), Pyridium (Phenazopyridine) and...
